Alpha 2.0
Login Register
» Articles » PMID: 32060559

Posaconazole-induced Pseudohyperaldosteronism Manifesting with Nephrotic-range Proteinuria

Overview
Journal Clin Infect Dis
Publisher Oxford University Press
Specialty Infectious Diseases
Date 2020 Feb 16
PMID 32060559
Citations 4
Authors
Ruth W Parker
Elise M N Ferre
Katherine Myint-Hpu
Monica M Schmitt
Ben Colton
Deborah P Merke
Michail S Lionakis
Affiliations
Soon will be listed here.
Citing Articles

Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study.

Liu Y, Qu R, Zhao Y, Wang Z, Yuan S, Liu S Int J Clin Pharm. 2024; .

PMID: 39644376 DOI: 10.1007/s11096-024-01841-8.

Characterization of the interferences of systemic azole antifungal drugs with adrenal steroid biosynthesis using H295R cells and enzyme activity assays.

Jager M, Joos F, Winter D, Odermatt A Curr Res Toxicol. 2023; 5:100119.

PMID: 37637492 PMC: 10458698. DOI: 10.1016/j.crtox.2023.100119.

Successful Treatment of Pneumonia and Lupus Nephritis With Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction-Induced Toxicity.

Pechacek J, Webb T, Ferre E, Schmitt M, DiMaggio T, Kobrin D Open Forum Infect Dis. 2023; 10(8):ofad410.

PMID: 37564740 PMC: 10411043. DOI: 10.1093/ofid/ofad410.

Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.

Ji H, Tang X, Zhang N, Huo B, Liu Y, Song L Antimicrob Agents Chemother. 2021; 66(1):e0166821.

PMID: 34662186 PMC: 8765306. DOI: 10.1128/AAC.01668-21.